Zinc finger X-chromosomal protein (ZFX) is a significant prognostic indicator and promotes cellular malignant potential in gallbladder cancer

References

• Li M, Zhang Z, Li X, Ye J, Wu X, Tan Z, Shen B, Wang XA, Wu W, Zhou D, et al. Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway. Nat Genet 2014; 46:872-6; PMID:24997986; http://dx.doi.org/10.1038/ng.3030
   PubMed Web of Science ®Google Scholar
• Wistuba, II, Gazdar AF. Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer 2004; 4:695-706; PMID:15343276; http://dx.doi.org/10.1038/nrc1429.
   PubMed Web of Science ®Google Scholar
• Li M, Zhang S, Wang Z, Zhang B, Wu X, Weng H, Ding Q, Tan Z, Zhang N, Mu J, et al. Prognostic significance of nemo-like kinase (NLK) expression in patients with gallbladder cancer. Tumour Biol 2013; 34:3995-4000; PMID:23857283; http://dx.doi.org/10.1007/s13277-013-0988-4.
   PubMed Web of Science ®Google Scholar
• Li M, Lu J, Zhang F, Li H, Zhang B, Wu X, Tan Z, Zhang L, Gao G, Mu J, et al. Yes-associated protein 1 (YAP1) promotes human gallbladder tumor growth via activation of the AXL/MAPK pathway. Cancer Lett 2014; 355:201-9; PMID:25218593; http://dx.doi.org/10.1016/j.canlet.2014.08.036.
   PubMed Web of Science ®Google Scholar
• Li M, Shen J, Wu X, Zhang B, Zhang R, Weng H, Ding Q, Tan Z, Gao G, Mu J, et al. Downregulated expression of hepatoma-derived growth factor (HDGF) reduces gallbladder cancer cell proliferation and invasion. Med Oncol 2013; 30:587; PMID:23609195; http://dx.doi.org/10.1007/s12032-013-0587-7.
   PubMed Web of Science ®Google Scholar
• Kang W, Tong JH, Chan AW, Lee TL, Lung RW, Leung PP, So KK, Wu K, Fan D, Yu J, et al. Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis. Clin Cancer Res 2011; 17:2130-9; PMID:21346147; http://dx.doi.org/10.1158/1078-0432.CCR-10-2467.
   PubMed Web of Science ®Google Scholar
• Tschaharganeh DF, Chen X, Latzko P, Malz M, Gaida MM, Felix K, Ladu S, Singer S, Pinna F, Gretz N, et al. Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma. Gastroenterology 2013; 144:1530-42 e12; PMID:23419361; http://dx.doi.org/10.1053/j.gastro.2013.02.009.
   PubMed Web of Science ®Google Scholar
• Wu C, Xu B, Yuan P, Miao X, Liu Y, Guan Y, Yu D, Xu J, Zhang T, Shen H, et al. Genome-wide interrogation identifies YAP1 variants associated with survival of small-cell lung cancer patients. Cancer Res 2010; 70:9721-9; PMID:21118971; http://dx.doi.org/10.1158/0008-5472.CAN-10-1493
   PubMed Web of Science ®Google Scholar
• Shao DD, Xue W, Krall EB, Bhutkar A, Piccioni F, Wang X, Schinzel AC, Sood S, Rosenbluh J, Kim JW, et al. KRAS and YAP1 converge to regulate EMT and tumor survival. Cell 2014; 158:171-84; PMID:24954536; http://dx.doi.org/10.1016/j.cell.2014.06.004.
   PubMed Web of Science ®Google Scholar
• Tan Z, Zhang S, Li M, Wu X, Weng H, Ding Q, Cao Y, Bao R, Shu Y, Mu J, et al. Regulation of cell proliferation and migration in gallbladder cancer by zinc finger X-chromosomal protein. Gene 2013; 528:261-6; PMID:23860324; http://dx.doi.org/10.1016/j.gene.2013.06.064.
   PubMed Web of Science ®Google Scholar
• Seton-Rogers S. Oncogenes: All eyes on YAP1. Nat Rev Cancer 2014; 14:514-5; PMID:25056702; http://dx.doi.org/10.1038/nrc3791.
   PubMed Web of Science ®Google Scholar
• Groot Koerkamp B, Fong Y. Outcomes in biliary malignancy. J Surg Oncol 2014; 110:585-91; PMID:25250887; http://dx.doi.org/10.1002/jso.23762.
   PubMed Web of Science ®Google Scholar
• Jiang R, Gao ZL, Sun M, Zhang XY, Wang JC, Wu H. Zinc finger X-chromosomal protein promotes growth and tumorigenesis in human osteosarcoma cells. Pak J Med Sci 2013; 29:997-1002; PMID:24353675.
   PubMed Web of Science ®Google Scholar
• Nikpour P, Emadi-Baygi M, Mohammad-Hashem F, Maracy MR, Haghjooy-Javanmard S. Differential expression of ZFX gene in gastric cancer. J Biosci 2012; 37:85-90; PMID:22357206; http://dx.doi.org/10.1007/s12038-011-9174-2.
   PubMed Web of Science ®Google Scholar
• Yang H, Lu Y, Zheng Y, Yu X, Xia X, He X, Feng W, Xing L, Ling Z. shRNA-mediated silencing of ZFX attenuated the proliferation of breast cancer cells. Cancer Chemother Pharmacol 2014; 73:569-76; PMID:24448637; http://dx.doi.org/10.1007/s00280-014-2379-y.
   PubMed Web of Science ®Google Scholar
• Li K, Zhu ZC, Liu YJ, Liu JW, Wang HT, Xiong ZQ, Shen X, Hu ZL, Zheng J. ZFX knockdown inhibits growth and migration of non-small cell lung carcinoma cell line H1299. Int J Clin Exp Pathol 2013; 6:2460-7; PMID:24228108.
   PubMed Web of Science ®Google Scholar
• Palmer CJ, Galan-Caridad JM, Weisberg SP, Lei L, Esquilin JM, Croft GF, Wainwright B, Canoll P, Owens DM, Reizis B. Zfx facilitates tumorigenesis caused by activation of the Hedgehog pathway. Cancer Res 2014; 74:5914-24; PMID:25164012; http://dx.doi.org/10.1158/0008-5472.CAN-14-0834.
   PubMed Web of Science ®Google Scholar
• Wu S, Lao XY, Sun TT, Ren LL, Kong X, Wang JL, Wang YC, Du W, Yu YN, Weng YR, et al. Knockdown of ZFX inhibits gastric cancer cell growth in vitro and in vivo via downregulating the ERK-MAPK pathway. Cancer Lett 2013; 337:293-300; PMID:23587796; http://dx.doi.org/10.1016/j.canlet.2013.04.003.
   PubMed Web of Science ®Google Scholar
• Akiyoshi S, Fukagawa T, Ueo H, Ishibashi M, Takahashi Y, Fabbri M, Sasako M, Maehara Y, Mimori K, Mori M. Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases. Br J Cancer 2012; 107:1345-53; PMID:22955854; http://dx.doi.org/10.1038/bjc.2012.326.
   PubMed Web of Science ®Google Scholar
• Jung KH, Kim JK, Noh JH, Eun JW, Bae HJ, Xie HJ, Ahn YM, Park WS, Lee JY, Nam SW, et al. Targeted disruption of Nemo-like kinase inhibits tumor cell growth by simultaneous suppression of cyclin D1 and CDK2 in human hepatocellular carcinoma. J Cell Biochem 2010; 110:687-96; PMID:20512928; http://dx.doi.org/10.1002/jcb.22579.
   PubMed Web of Science ®Google Scholar
• Tan Z, Li M, Wu W, Zhang L, Ding Q, Wu X, Mu J, Liu Y. NLK is a key regulator of proliferation and migration in gallbladder carcinoma cells. Mol Cell Biochem 2012; 369:27-33; PMID:22733362; http://dx.doi.org/10.1007/s11010-012-1365-0.
   PubMed Web of Science ®Google Scholar
• Simpson DR, Mell LK, Cohen EE. Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck. Oral Oncol 2015; 51:291-8; PMID:25532816; http://dx.doi.org/10.1016/j.oraloncology.2014.11.012.
   PubMed Web of Science ®Google Scholar
• Li D, Zhao LN, Zheng XL, Lin P, Lin F, Li Y, Zou HF, Cui RJ, Chen H, Yu XG. Sox2 is involved in paclitaxel resistance of the prostate cancer cell line PC-3 via the PI3K/Akt pathway. Mol Med Rep 2014; 10:3169-76; PMID:25310235.
   PubMed Web of Science ®Google Scholar
• Sherr CJ. Cancer cell cycles. Science 1996; 274:1672-7; PMID:8939849; http://dx.doi.org/10.1126/science.274.5293.1672.
   PubMed Web of Science ®Google Scholar
• Vlug EJ, van de Ven RA, Vermeulen JF, Bult P, van Diest PJ, Derksen PW. Nuclear localization of the transcriptional coactivator YAP is associated with invasive lobular breast cancer. Cell Oncol (Dordr) 2013; 36:375-84; PMID:23949920; http://dx.doi.org/10.1007/s13402-013-0143-7.
   PubMed Web of Science ®Google Scholar